Kahveci AM, Tahan V. Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies. Turkish Journal of Gastroenterology [Internet]. 2016 Jan. 1 [cited 2026 Jan. 1];27(1):89-90. Available from: https://www.turkjgastroenterol.org/index.php/tjg/article/view/2845